CGTLimited DatastaleNational Cancer Institute (NCI)Phase 1
mCD19-CAR-CD28-CD3-zeta. (anti-CD19 CAR, mCD19-CAR-CD28-CD3-zeta., mCD19-CAR-CD28-CD3-zeta.(anti-CD19 CAR) retroviral vector-transduced allogeneic peripheral blood lymphocytes (PBL))
Hematologic Malignancies; Hematologic Neoplasms · CD19
#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting